ghk-cu 100 100mg GHK-Cu Peptide – Anti-Aging &

Research suggests it may influence fibroblast activity and extracellular matrix synthesis, though clinical applications remain exploratory

Dose-by-dose weight loss in Phase 2 (NEJM) Phase 2 NEJM weight loss by dose, 24 and 48 weeks Dose 1 mg 24 weeks -7.2% 48 weeks -8.7% Dose 4 mg 24 weeks -12.9% 48 weeks -17.5% Dose 8 mg 24 weeks -15.7% 48 weeks -22.8% Dose 12 mg 24 weeks -17.5% 48 weeks -24.2% Dose Placebo 24 weeks -1.6% 48 weeks -2.1% Source: Jastreboff et al., NEJM 2023

Room temperature exposure should be limited to brief handling or shipping periods only

I would recommend this product

Per the company's published return terms, customers not fully satisfied may contact the Santa Barbara, CA office for a full refund